Alcohol Use During Pregnancy in Finland According to Meconium Samples

Raskaudenaikaiset Elintavat ja Etyyliglukuronidin Esiintyminen Mekoniumissa Suomessa

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04918043

Acronym

RASMEK21

Enrollment

1000

Registered

2021-06-08

Start date

2021-06-01

Completion date

2021-08-30

Last updated

2021-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Alcohol Spectrum Disorders

Brief summary

Meconium samples are collected anonymously from newborns in Helsinki University Hospital maternity ward. The study tries to to find how many women continue to use alcohol during the second half of the pregnancy. Meconium samples are tested for ethylglucuronide (EtG), a metabolite of ethanol, that accumulates in the meconium. Altogether 1000 samples are taken. The sample results are compared to anonymously answered questionnaire about alcohol use.

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

No minimum to 3 Days

Healthy volunteers

Yes

Inclusion criteria

* newborn baby

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
EtG	Once	The meconium samples from newborns are tested for ethyl glucuronide using LC-MS/MS mass spectrometry.

Contacts

Primary ContactMikko Koivu-Jolma

mikko.koivu-jolma@helsinki.fi+358414873836

Outcome results